Singapore markets close in 7 hours 15 minutes
Straits Times Index
3,252.01 -12.52 (-0.38%) Nikkei
38,258.48 +56.11 (+0.15%) Hang Seng
18,337.15 +23.29 (+0.13%) FTSE 100
8,354.05 +40.38 (+0.49%) Bitcoin USD
61,449.61 -1,126.25 (-1.80%) CMC Crypto 200
1,309.89 +15.22 (+1.18%)
Jazz Pharmaceuticals plc (JAZZ)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 6.98B |
| Enterprise value | 10.95B |
| Trailing P/E | 22.92 |
| Forward P/E | 5.62 |
| PEG ratio (5-yr expected) | 0.79 |
| Price/sales (ttm) | 1.99 |
| Price/book (mrq) | 1.89 |
| Enterprise value/revenue | 2.85 |
| Enterprise value/EBITDA | 9.38 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.61 |
| 52-week change 3 | -19.25% |
| S&P500 52-week change 3 | 25.59% |
| 52-week high 3 | 146.70 |
| 52-week low 3 | 103.01 |
| 50-day moving average 3 | 115.36 |
| 200-day moving average 3 | 124.77 |
Share statistics
| Avg vol (3-month) 3 | 652.62k |
| Avg vol (10-day) 3 | 704.16k |
| Shares outstanding 5 | 63.04M |
| Implied shares outstanding 6 | 63.13M |
| Float 8 | 61.25M |
| % held by insiders 1 | 2.79% |
| % held by institutions 1 | 96.70% |
| Shares short (15 Apr 2024) 4 | 3.7M |
| Short ratio (15 Apr 2024) 4 | 5.44 |
| Short % of float (15 Apr 2024) 4 | 7.73% |
| Short % of shares outstanding (15 Apr 2024) 4 | 5.87% |
| Shares short (prior month 15 Mar 2024) 4 | 2.77M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 8.61% |
| Operating margin (ttm) | 11.66% |
Management effectiveness
| Return on assets (ttm) | 4.07% |
| Return on equity (ttm) | 9.41% |
Income statement
| Revenue (ttm) | 3.84B |
| Revenue per share (ttm) | 60.96 |
| Quarterly revenue growth (yoy) | 1.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.37B |
| Net income avi to common (ttm) | 330.79M |
| Diluted EPS (ttm) | 4.83 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.82B |
| Total cash per share (mrq) | 28.92 |
| Total debt (mrq) | 5.79B |
| Total debt/equity (mrq) | 156.50% |
| Current ratio (mrq) | 2.27 |
| Book value per share (mrq) | 58.65 |
Cash flow statement
| Operating cash flow (ttm) | 1.04B |
| Levered free cash flow (ttm) | 1.04B |
© 2024 Yahoo. All rights reserved.